Florian Schönharting
Founder chez GH RESEARCH PLC
Fortune : 262 M $ au 31/03/2024
Profil
Florian Schönharting is the founder of ACADIA Pharmaceuticals, Inc. (founded in 1993), Genmab A (founded in 1999), Nordic Biotech Advisors ApS (founded in 2001), Forward Pharma A (founded in 2005), and GH Research Plc (founded in 2018).
He holds the title of Chief Executive Officer at Nordic Biotech Advisors ApS and Chairman at Forward Pharma A and GH Research Plc.
Mr. Schönharting is also the founder of Zealand Pharma A and Life Cycle Pharma A.
Mr. Schönharting's current job(s) include Chairman at GH Research Ireland Ltd., Director at Danish Corporate Governance Association, and Manager at Tech Growth Invest ApS.
Mr. Schönharting's former job(s) include Director at Osteologix, Inc., Rose Pharma A, Osteologix Holdings Plc, Spree Pharma A, Blue Note Pharmaceuticals BV, and Aditech Pharma AB.
Mr. Schönharting's education history includes graduating from Copenhagen Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GH RESEARCH PLC
28,49% | 31/12/2023 | 14 824 419 ( 28,49% ) | 158 M $ | 31/03/2024 |
| 01/03/2023 | 2 051 961 ( 3,42% ) | 103 M $ | 31/03/2024 | |
| 28/02/2023 | 6 567 249 ( 1,89% ) | 807 772 $ | 31/03/2024 |
Postes actifs de Florian Schönharting
| Sociétés | Poste | Début |
|---|---|---|
| FORWARD PHARMA A/S | Founder | 01/07/2005 |
| GH RESEARCH PLC | Founder | 01/01/2018 |
Nordic Biotech Advisors ApS
 Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | Chief Executive Officer | 01/07/2001 |
GH Research Ireland Ltd.
 GH Research Ireland Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2018, GH Research Ireland Ltd. is an Irish clinical-stage biopharmaceutical company that develops innovative therapies for the treatment of mental illnesses. The private company is based in Dublin, Ireland and is a subsidiary of GH Research Plc. | Chairman | - |
Tech Growth Invest ApS
 Tech Growth Invest ApS Financial ConglomeratesFinance Part of Holdingselskabet AF 2013 ApS, Tech Growth Invest ApS is an investment holding Danish company. The private company is based in Copenhagen, Denmark. | Corporate Officer/Principal | - |
| Danish Corporate Governance Association | Director/Board Member | - |
Anciens postes connus de Florian Schönharting
| Sociétés | Poste | Fin |
|---|---|---|
Blue Note Pharmaceuticals BV
 Blue Note Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Blue Note Pharmaceuticals is a privately held biopharmaceutical company with offices in Troy, New York and Amsterdam, The Netherlands. Blue Note's mission is to acquire, advance, develop, partner and commercialize carefully selected undervalued drug development candidates with the potential to more effectively treat or help prevent major medical conditions affecting society. The Company's lead development project is BNP 32,762, a pharmacokinetically unique calcium channel blocker (CCB) being evaluated in late-stage clinical trials for the treatment of hypertension and chronic stable angina. Blue Note is also evaluating various products that would combine BNP 32,762 with other commonly accepted antihypertensive drugs such as ACE inhibitors, Angiotensin Receptor Blockers (ARBs) and diuretics. The Company's cardiovascular-oriented pipeline also includes an early-stage program for the prevention of Deep Vein Thrombosis (DVT) and for the treatment of a number of other important cardiovascular indications. | Director/Board Member | 04/02/2014 |
Rose Pharma A/S
 Rose Pharma A/S Pharmaceuticals: MajorHealth Technology Rose Pharma A/S provides pharmaceutical products for treatment of pain in connection with irritable bowel syndrome. It develops treatments for irritable bowel syndrome (IBS) and functional dyspepsia, and disorders. The firm focuses on the medical applications of gastrointestinal hormones. The company was founded in 2003 and is headquartered in Roskilde, Denmark. | Director/Board Member | 27/06/2012 |
Spree Pharma A/S
 Spree Pharma A/S Pharmaceuticals: MajorHealth Technology Spree Pharma A/S develops and markets therapeutic indications. It engages in the selection of drug compounds for reformulation using EON platform. The company was founded in 2007 and is headquartered in Copenhagen, Denmark. | Director/Board Member | 06/06/2011 |
| ░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Florian Schönharting
| Copenhagen Business School | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| GENMAB A/S | Health Technology |
| ZEALAND PHARMA A/S | Health Technology |
| GH RESEARCH PLC | Health Technology |
| Entreprise privées | 12 |
|---|---|
| Osteologix, Inc. /Old/ | Health Technology |
Nordic Biotech Advisors ApS
Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | Finance |
Rose Pharma A/S
Rose Pharma A/S Pharmaceuticals: MajorHealth Technology Rose Pharma A/S provides pharmaceutical products for treatment of pain in connection with irritable bowel syndrome. It develops treatments for irritable bowel syndrome (IBS) and functional dyspepsia, and disorders. The firm focuses on the medical applications of gastrointestinal hormones. The company was founded in 2003 and is headquartered in Roskilde, Denmark. | Health Technology |
Osteologix Holdings Plc
 Osteologix Holdings Plc Pharmaceuticals: OtherHealth Technology Osteologix Holdings Plc engaged in the development of innovative pharmaceuticals for the treatment and prevention of bone and joint tissues diseases. The company was founded in October 2004 and was headquartered in Dublin, Ireland. | Health Technology |
| Danish Corporate Governance Association | |
Forward Pharma A/S
 Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Forward Pharma A/S is a biopharmaceutical company, which engages in the research and development of medicinal treatment for inflammatory and neurological indications. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company was founded by Florian Schönharting on July 2005 and is headquartered in Copenhagen, Denmark. | Health Technology |
Spree Pharma A/S
Spree Pharma A/S Pharmaceuticals: MajorHealth Technology Spree Pharma A/S develops and markets therapeutic indications. It engages in the selection of drug compounds for reformulation using EON platform. The company was founded in 2007 and is headquartered in Copenhagen, Denmark. | Health Technology |
Blue Note Pharmaceuticals BV
Blue Note Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Blue Note Pharmaceuticals is a privately held biopharmaceutical company with offices in Troy, New York and Amsterdam, The Netherlands. Blue Note's mission is to acquire, advance, develop, partner and commercialize carefully selected undervalued drug development candidates with the potential to more effectively treat or help prevent major medical conditions affecting society. The Company's lead development project is BNP 32,762, a pharmacokinetically unique calcium channel blocker (CCB) being evaluated in late-stage clinical trials for the treatment of hypertension and chronic stable angina. Blue Note is also evaluating various products that would combine BNP 32,762 with other commonly accepted antihypertensive drugs such as ACE inhibitors, Angiotensin Receptor Blockers (ARBs) and diuretics. The Company's cardiovascular-oriented pipeline also includes an early-stage program for the prevention of Deep Vein Thrombosis (DVT) and for the treatment of a number of other important cardiovascular indications. | Health Technology |
Aditech Pharma AB
 Aditech Pharma AB Pharmaceuticals: MajorHealth Technology Aditech Pharma AB develops and manufactures pharmaceutical products. It offers furmaric acid esters used for the treatment of psoriasis, inflammatory, and autoimmune disorders. The company is headquartered in Tygelsjo, Sweden | Health Technology |
| Life Cycle Pharma A/S | |
Tech Growth Invest ApS
Tech Growth Invest ApS Financial ConglomeratesFinance Part of Holdingselskabet AF 2013 ApS, Tech Growth Invest ApS is an investment holding Danish company. The private company is based in Copenhagen, Denmark. | Finance |
GH Research Ireland Ltd.
GH Research Ireland Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2018, GH Research Ireland Ltd. is an Irish clinical-stage biopharmaceutical company that develops innovative therapies for the treatment of mental illnesses. The private company is based in Dublin, Ireland and is a subsidiary of GH Research Plc. | Commercial Services |
